Author:
Menko Fred H.,Jeanson Kiki N.,Bleiker Eveline M. A.,van Tiggelen Carla W. M.,Hogervorst Frans B. L.,ter Stege Jacqueline A.,Ait Moha Daoud,van der Kolk Lizet E.
Publisher
Springer Science and Business Media LLC
Subject
Genetics (clinical),Genetics
Reference24 articles.
1. Szabo CI, King MC. Inherited breast and ovarian cancer. Hum Mol Genet. 1995;4:1811–7.
2. Hereditary Tumours. Guidelines for Diagnosis and Prevention. Leiden:The Netherlands Foundation for the Detection of Hereditary Tumours and Dutch Society for Clinical Genetics; 2010. ISBN 978-90-806183-2-9 (in Dutch).
3. Golmard L, Delnatte C, Laugé A, Moncoutier V, Lefol C, Abidallah K, et al. Breast and ovarian cancer predisposition due to de novo BRCA1 and BRCA2 mutations. Oncogene. 2016;35:1324–7.
4. Tuffaha HW, Mitchell A, Ward BL, Connely L, Butler JRG, Norris S, et al. Cost-effectiveness analysis of germ-line BRCA testing in women with breast cancer and cascade testing in family members of mutation carriers. Genet Med. 2018;20:985–94.
5. Menko FH, ter Stege JA, van der Kolk LE, Jeanson KN, Schats W, Moha DA, et al. The uptake of presymptomatic genetic testing in hereditary breast-ovarian cancer and Lynch syndrome: a systematic review of the literature and implications for clinical practice. Fam Cancer. 2019;18:127–35.
Cited by
22 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献